Otsuka

News

Otsuka’s lupus nephritis drug Lupkynis backed for NHS use

Patients in England and Wales with active lupus nephritis will soon be able to access treatment with Otsuka Pharma’s Lupkynis following a recommendation by the health tech

News

Rexulti backed for Alzheimer’s agitation by FDA adcomm

Otsuka and Lundbeck’s antidepressant Rexulti should be approved to treat Alzheimer’s disease-related agitation (AAD), according to FDA advisors – a move that could unlock

News

Otsuka, Aurinia claim EU okay for oral lupus nephritis drug

Aurinia Pharma and partner Otsuka have secured approval in the EU for Lupkynis, billed as the first oral treatment for active nephritis in patients with the autoimmune disease systemic lupu

News

Otsuka backs GrayMatters' digital wearable tech for mental d...

Japanese pharma group Otsuka has led a $10 million first-round financing of GrayMatters Health, an Israeli company developing a digital he

News

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.

Otsuka dips its toe in psychedelic waters, backing Mindset P...

Despite the growing interest in developing medicines based on psychedelic compounds, big pharma has seemed a bit wary of getting involved, leaving the task to small start-ups.

News

Novi Sad, Serbia - October 6, 2014: Woman's hands Googling on electronic device.Woman hands holding and touching on Apple iPad mini with Google search web page on a screen.

Otsuka, Click trial digital depression therapy with Google

Otsuka and Click Therapeutics are working with Verily, the healthcare subsidiary of Google owners Alphabet, on a fully remote clinical trial testing a digital therapy as an add-on in adults

Otsuka’s lupus nephritis drug Lupkynis backed for NHS use

Rexulti backed for Alzheimer’s agitation by FDA adcomm

Otsuka, Aurinia claim EU okay for oral lupus nephritis drug

Otsuka backs GrayMatters' digital wearable tech for mental d...

Otsuka dips its toe in psychedelic waters, backing Mindset P...

Otsuka, Click trial digital depression therapy with Google

Doctors dismayed by report of NHS AI proposal

Discover a new era of healthcare panel engagement: Grounded ...

Otsuka

Editor's Picks